STAT December 23, 2025
John Wilkerson, Elaine Chen

Some drugmakers that struck individual deals with Trump say they’re exempt from the Medicare effort

Many of the largest drugmakers may be exempt from Medicare pilot programs intended to force them to lower some of their prices, potentially undermining the effort and depriving American patients of cheaper drugs.

Several of the 14 pharmaceutical companies that have struck individual drug-pricing deals with the White House said they are exempt from the Medicare effort. The terms of those deals have not been disclosed, and the Centers...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

Continue Reading

 
Topics: Biotechnology, Insurance, Medicare, Pharma, Pharma / Biotech
Related Articles:
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery

Share Article